Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema - 03/09/11
, Antje Söfker, MD aAbstract |
PURPOSE: To report the clinical outcome of a diabetic patient with macular edema treated with an intravitreal injection of crystalline cortisone.
METHODS: Interventional case report. A 73-year-old patient with diabetes mellitus presented with clinically significant diffuse macular edema caused by nonproliferative diabetic retinopathy. Despite grid laser coagulation in the macular region, cystoid macular edema progressed, and within 6 months before the cortisone injection, visual acuity declined from 0.25 to 0.16 and, finally, to 0.10. The patient received a single intravitreal injection of triamcinolone acetonide with topical anesthesia.
RESULTS: After the intravitreal injection of triamcinolone acetonide, visual acuity improved from 0.10 to 0.40 during the follow-up period spanning 5 months. Intraocular pressure increased to values up to 30 mm Hg before antiglaucomatous treatment.
CONCLUSION: Intravitreal injection of triamcinolone acetonide may be useful for treatment of diabetic macular edema resistant to conventional therapy.
Le texte complet de cet article est disponible en PDF.
Vol 132 - N° 3
P. 425-427 - septembre 2001 Retour au numéro
Article précédent
- Central serous chorioretinopathy after epidural corticosteroid injection
- Tomohiro Iida, Richard F Spaide, Silvana G Negrao, Cynthia A Carvalho, Lawrence A Yannuzzi
- Upregulation of pigment epithelium-derived factor after laser photocoagulation
- Nahoko Ogata, Joyce Tombran-Tink, Nobuo Jo, David Mrazek, Miyo Matsumura
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?